The trial, known as the Purpose 1 trial, involved 5,000 participants across multiple sites and compared the efficacy of lenacapavir with two other PrE...
Stay ahead of the news! Click ‘Yes, Thanks’ to receive breaking stories and exclusive updates directly to your device. Be the first to know what’s happening.